Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tonix Pharm Holdings (NQ: TNXP )

0.3600 -0.0200 (-5.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40,430,497
Open 0.3400
Bid (Size) 0.4000 (89)
Ask (Size) 0.4049 (50)
Prev. Close 0.3800
Today's Range 0.3259 - 0.3806
52wk Range 0.3259 - 32.32
Shares Outstanding 22,004,159
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
Tonix Pharmaceuticals shares are traded lower on Tuesday. The stock is pulling back after a 60% gain on Monday following the company's Q2 earnings report. 
Via Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga

Performance

YTD
-97.31%
-97.31%
1 Month
-36.10%
-36.10%
3 Month
-93.89%
-93.89%
6 Month
-96.99%
-96.99%
1 Year
-98.82%
-98.82%

More News

Read More
TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests
Via Benzinga
Peering Into Tonix Pharmaceuticals's Recent Short Interest
Via Benzinga
FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate
Via ACCESSWIRE
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
Via FinancialNewsMedia
Exposures Product Safety
Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral
Via ACCESSWIRE
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
From FN Media Group LLC
Via GlobeNewswire
Tonix Pharmaceuticals receives positive feedback from FDA on Tonmya™ for fibromyalgia management
Via News Direct
Exposures Product Safety
Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025
Via ACCESSWIRE
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Tonix Pharmaceuticals (TNXP) Stock Is Falling
Via Benzinga
7 F-Rated Stocks To Sell in July
Via InvestorPlace
Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract
Via Benzinga
AMZN Stock Alert: Amazon Just Joined the $2 Trillion Club
Via InvestorPlace
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Nike, Micron And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
7 F-Rated Penny Stocks to Avoid This June
Via InvestorPlace
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
This Biopharma Stock Is Trading 23% Higher In Pre-Market After Wrapping Up $4M Public Offering
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.